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Abstract
The ageing revolution is changing the composition of our society with more people becoming very old with higher risks for
developing both pain and dementia. Pain is normally signaled by verbal communication, which becomes more and more
deteriorated in people with dementia. Thus, these individuals unnecessarily suffer from manageable but unrecognized pain. Pain
assessment in patients with dementia is a challenging endeavor, with scientific advancements quickly developing. Pain assessment
tools and protocols (mainly observational scales) have been incorporated into national and international guidelines of pain
assessment in aged individuals. To effectively assess pain, interdisciplinary collaboration (nurses, physicians, psychologists,
computer scientists, and engineers) is essential. Pain management in this vulnerable population is also preferably done in an
interdisciplinary setting. Nonpharmacological management programs have been predominantly tested in younger populations
without dementia. However, many of them are relatively safe, have proven their efficacy, and therefore deserve a first place in pain
management programs. Paracetamol is a relatively safe and effective first-choice analgesic. There aremany safety issues regarding
nonsteroidal anti-inflammatory drugs, opioids, and adjuvant analgesics in dementia patients. It is therefore recommended to
monitor both pain and potential side effects regularly. More research is necessary to provide better guidance for pain management
in dementia.
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1. Epidemiology
1.1. The demographic revolution puts pain in dementia in
the spotlight
In the 20th century, the world population has seen an incredible
growth in life expectancy. First, reduced mortality in the first years
in life was responsible for this growth, but in the past decades,
and in the coming decades, the growth is now impacted by many
already “old” people (older than 60 years) getting “very old” (older
than 80 years). Larger proportions of people in most societies will
be relatively older and the absolute number of very old persons is
rapidly growing around the globe.66 This also changes the
spectrum of morbidity with many more age-related diseases,
such as dementia, assuming a more prominent place in health
care use, caregiver burden, and health care costs. Pain is also
related to age and therefore the prevalence of pain and chronic
pain is rising alongside the morbidity that it is associated
with.2,22,57 Arthritis, in particular, is one of the diseases that is
responsible for considerable pain in older persons.78
Unfortunately, the consequences of pain are more severe in
older populations, especially on functional independence and
social participation. The combination of a much higher preva-
lence with more severe consequences escalates pain in de-
mentia to an important societal, clinical, and scientific challenge.
1.2. What do we know of pain in the different subtypes
of dementia?
Dementia is a syndrome that can lead to confusion, memory loss,
neuropsychiatric symptoms, and sometimes physical chal-
lenges. The Diagnostic and Statistic Manual of Mental Disorders
Fifth Edition (DSM-5) does not mention dementia, but instead
uses the term neurocognitive disorders, and classifies it asmild or
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Key Points
1. Pain in dementia is very prevalent and difficult to assess.
Next to easy self-report measures, observational instru-
ments are necessary in clinical practice.
2. Nonpharmacological management programs are the first
line of choice, often in combination with analgesics.
3. Paracetamol is relatively safe in this population, and safety
issues with other analgesics (eg, nonsteroidal anti-
inflammatory drugs, opioids, and adjuvants) should be
considered with careful risk/benefit analysis for each in-
dividual to achieve quality pain care.
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major, on how severely the symptoms impact a person’s ability to
function independently in everyday activities.5
In a recent U.S. study, most patients with dementia were
diagnosed with dementia not otherwise specified, with Alz-
heimer’s disease (AD) being the most prevalent subtype.31 In the
early stages, people with AD may find it hard to remember recent
events, conversations, and names of people. In time, it becomes
harder to communicate and judgment may become impaired.
The person may feel disoriented and confused. Their behavior
can change, and physical activities, such as swallowing and
walking, will become harder. Vascular dementia (VD) is another
highly prevalent cause of dementia, followed by Lewy body
dementia and frontotemporal dementia (FTD).31 Often, people
have mixed types of dementia, with both aspects of AD (such as
amyloid plaques) and VD (white matter lesions). Also, other
neurodegenerative diseases such as Parkinson disease and
Huntington disease often are accompanied by dementia in the
last stages of the disease. To know what the effects of pain are in
different subtypes of dementia, several things have to be taken
into account:
(1) The more general problems that arise in most type of
dementias, such as difficulty in abstract thinking and verbal
communication, and
(2) the location of the neuropathology.
The more general problems with abstract thinking and
communication will be discussed in the assessment of pain in
dementia. Here, wewill discuss the specifics of different dementia
subtypes related to the neuropathology, although we have only
a few studies that look at pain in defined specific dementia
populations.11
In AD, the classic neuropathological changes are predomi-
nantly in the temporal and parietal cerebral cortex and
hippocampus. This neuropathology definitely is affecting several
pain centers in the brain. Earlier work postulated that people with
AD therefore, although theywould be able to sense pain, could be
less emotionally affected by it.58 However, several experimental
studies have shown that it is unlikely that this is the case: both
pain reflex studies and fMRI studies after pain stimulus show that
the reaction to pain of patients with AD is even more
pronounced.20
Vascular dementia has been associated with slightly higher
pain prevalences, probably because of the possibility that the
brain white matter lesions are the cause of central pain.59 One of
the most recent studies on pain in VD suggests that people with
VD have a similar pain intensity as cognitively intact persons, but
seem to suffer more from it.60
Frontotemporal dementia and pain has only been investigated
in 2 studies, one of them being experimental. Based on these
studies, we assume that it is possible that patients with FTD have
an increase in pain threshold, and possibly also in pain tolerance.9
Thus, different dementia types may experience pain differently.
However, in the 2 most frequent forms of dementia, namely AD
and VD, there is no indication for a reduced but instead for an
augmented vulnerability to pain.
1.3. Prevalence of pain in dementia
In the community, more than half of the patients with dementia
experience daily pain.8 In nursing homes around 60% to 80% of
people with dementia regularly experience pain.17 There are
many different causes, such as musculoskeletal, gastrointestinal,
and cardiac conditions, but also genitourinary infections and
wounds, such as pressure ulcers.17 Not all patients experiencing
pain have chronic pain, but those who have are more likely to
have an accelerated memory decline.52 Approximately 1 in 3
residents have moderate to severe pain, and patients with more
severe dementia experience more pain than those with less
severe dementia.73 In a recent study, nociceptive pain has been
found as the most prominent type (70%) in a nursing home
population, followed by amix of nociceptive and neuropathic pain
(25%).73
Of particular interest is orofacial pain, which is related to poor
oral health care. It is prevalent in around 10% of the patients with
dementia and may cause significant suffering.70
1.4. Consequences of pain in dementia
There is some evidence that pain in dementia is related to
a variety of behavioural symptoms, such as depression,
verbal abuse, wandering, agitation, and aggression.67 The
relation of pain with functional impairment has not been
studied so well in the dementia population, or studies were of
low methodological quality. The one that was of relatively
good quality showed a relation between pain and functional
impairment.45
2. Pain assessment in patients with dementia
Competent pain assessment is a necessary prerequisite for good
pain management and ideally considers several pain dimensions,
namely intensity, location, affect, cognition, behavior, and social
accompaniments. In case of patients with dementia, many
cognitive and linguistic barriers prevent individuals from focusing
on all these aspects. Those responsible for pain management
must be adequately informed at the least about the presence and
intensity of pain. Thus, limited and one-sided pain assessment is
almost the rule in individuals with dementia, leading to deleterious
consequences for their pain treatment or lack thereof.12 The best-
possible forms of pain assessment will be briefly reviewed in the
next paragraphs.
2.1. Self-report
The gold standard in pain assessment is the self-report either in
less standardized forms as asked in interviews or in more
standardized forms as requested in pain scales.50 Although it lies
in the nature of the disease “dementia” that the capacity of self-
monitoring inner states and reflecting them appropriately in self-
report statements deteriorates over time and finally gets lost, self-
report of pain should not be disregarded too early but still sought
in mild to moderate forms of dementia. Referring to the Mini
Mental State Examination,29 a cutoff score of 18 was suggested
to divide individuals into those still able and those no longer able
to self-report pain.15 However, it is necessary to adapt the form of
self-report to the individual capabilities of the patient. The
frequently used visual analogue scale, which requests the
matching of a line length to the experienced intensity of pain, is
far beyond the cognitive level of most patients even in early stages
of dementia. Simple numerical or verbal scales and—later in the
course of dementia—even simpler categorical questions (to be
answered with “yes” or “no”) should be used. However, even
minimal knowledge in the patients about the requests associated
with answering certain simple scales does not always guarantee
valid self-report of pain. Therefore, from a certain degree of
cognitive and linguistic impairment on, it is advised to add an
observer tool to self-report assessment, which takes on the
leading role more and more in later stages of dementia. Thus,
besides direct pain testing, neuropsychological screening of the
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cognitive status should become routine to become sensitive for
the transition from possible to invalid self-report.
2.2. Observer ratings
There is general agreement that observer ratings of pain
organized in short scales are necessary in moderate and severe
forms of dementia to get valid and reliable information about the
presence and intensity of pain. In addition, there is also wide
agreement that 3 behavioral domains mirror pain-related states,
which are namely facial responses, vocalization, and body
movement or body posture.75 There are meanwhile numerous
observer-rating scales available based on this principal, which,
however, disagree substantially in the selection of the exact items
for the 3 domains. A survey of the available scales is given in
Table 1.
The problems associated with these scales include poor or
unproven reliability, lack of evidence for validity, and untested
sensitivity of change. Also, implementation in practice is poor.
However, even if the optimal tool has not yet been developed, it
has turned out that as soon as any attempt of systematic pain
assessment by such scales was implemented in nursing homes,
pain management improved.54 Thus, it will be important to
convince the end-users (mainly geriatric nurses) to apply such
scales and help to further improve their usability.
The imperfect state of development of most observer-rating
scales has inspired an American and a European research group
to develop meta-tools out of the existing observer-rating scales,
which try to make use of only the best possible items available.
These attempts have become obtainable in 2 scales, namely Pain
Intensity Measure for Persons with Dementia (available in
English27) and PAIC-15 (Pain Assessment in Impaired Cognition;
available in English and 8 other languages18,21,41,68) and await
further testing.
A special challenge is pain assessment in end-of-life care,
which requires special instruments with more focus on psycho-
logical distress. A few instruments are yet become available.71
2.3. Experimental methods
Experimental methods such as pain psychophysics (eg, pain
threshold and tolerance threshold), brain imaging, neurophysio-
logic recordings (eg, SSEP and R-III reflex), and facial response
coding are not easily used in the clinical context for pain
assessment and are mainly reserved for research on individuals
with dementia.39 Their great relevance is the demonstration of
changes in nociception and pain processing associated with
various forms of dementia (see paragraph “what do we know of
pain in the different subtypes of dementia?” in this article). Thus,
we now also know that the brain changes associated with
dementia do not reduce pain to a degree, which make further
attempts of pain management unnecessary. By contrast, most
forms of dementia are even associated with enhanced nocicep-
tion and pain processing.
Table 1
Survey of the most frequently used observational scales according to Zwakhalen et al.80 (2017; modified form).
Observational scales Available versions Authors
The Abbey Pain Scale English, Italian, Japanese Abbey et al.,1 2004
Algoplus English, French Rat et al.,53 2011
Checklist of Nonverbal Pain Indicators (CNPI) English, Norwegian Feldt, 200028
CNA Pain Assessment Tool (CPAT) English Cervo et al.,13 2009
Doloshort French Pautex et al.,49 2009
Doloplus-2 Chinese, Dutch, English, French, Italian,
Japanese, Norwegian, Portuguese, Spanish
Levebre-Chapiro, 200143
Discomfort Scale for Dementia of the
Alzheimer’s Type (DS-DAT)
Dutch, English, Italian Hurley et al.,32 1992
Elderly Pain Caring Assessment (EPCA-2) French Morello et al.,48 2007
Mahoney Pain Scale (MPS) English Mahoney and Peters, 200847
Mobilization-Observation-Behavior-Intensity-
Dementia (MOBID and MOBID-2)
Norwegian Husebo et al.,33 2007
Noncommunicating Patient’s Pain Assessment
Instrument (NOPPAIN)
Brazilian, English, Italian, Portuguese Snow et al.,63 2004
The Pain Assessment in the Cognitively Impaired
(PACI)
English Kaasalainen et al.,36,37 2011
The Pain Assessment Scale for Seniors with
Severe Dementia (PACSLAC)
Dutch, English, French, Japanese, Portuguese Fuchs-Lacelle and Hadjistavropoulos, 200430
PACSLAC-D Dutch Zwakhalen et al.,79 2007
PACSLAC 2 English Chan et al.,14 2014
Pain Assessments in Dementing Elders (PADE) English Villanueva et al.,74 2003
The Pain Assessment in Advanced Dementia
Scale (PAINAD)
Chinese, Dutch, English, German, Italian,
Portuguese, Spanish
Warden et al.,75 2003
Pain Assessment in Noncommunicative Elderly
Persons (PAINE)
English Cohen-Mansfield, 200616
Rotterdam Elderly Pain Observation Scale
(REPOS)
Dutch, English van Herk et al.,72 2008
Bold denotes scales, which can be especially recommended according to others,46,61 and one of the present authors (S.L.).
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2.4. Automatic pain recognition
The technical attempts of finding solutions to the problem of
automatic pain recognition aremeanwhile numerous and seem to
be ideal for assisting pain measurement in noncommunicative
(nonverbal) individuals.19,40 They are mainly video-based and
target facial responses to pain but may add biosignals (eg, ECG,
blood pressure, and EEG) and actigraphy. The momentarily
available solutions may help to assess the immobile, bedridden
patients under ideal conditions of illumination and no visual
overlap, who show prototypical pain behavior without masking by
the expression of other emotions. Furthermore, the machine
learning algorithms applied for pain recognition are mainly trained
on young individuals, which already let wrinkles invalidate this
form of computer-driven pain diagnostics.7 In other words, use in
the uncontrolled clinical environments of hospitals and care units
in nursing homes is still out of reach.
For progress towards automatic pain recognition, interdisci-
plinary collaboration (nurses, physicians, psychologists, com-
puter scientists, and engineers) is mandatory.
3. New developments in
nonpharmacological management
Complexities of pain in older persons with dementia necessi-
tate a comprehensive pain management approach that
encompasses more than pharmacotherapy. For years, clinical
practice guidelines have recommended incorporation of non-
pharmacologic approaches as part of the pain management
plan for older adults,2 but recent concern related to opioid use
for chronic pain has increased attention to the effective use of
nondrug approaches.65 Incorporation of nondrug techniques
involves careful consideration of the unique patient circum-
stances, patient preferences, and evidence of effectiveness
and guidance for selection of these interventions in the frail
older person with dementia. Although evidence is growing, the
majority of evidence for nondrug pain interventions has been
conducted in cognitively intact older adults because those with
dementia are typically excluded from most randomized control
trials (RCTs). Evidence is accumulating on nondrug interven-
tions to manage behavioral and psychological symptoms of
dementia (BPSD), but few studies focus specifically on pain as
the outcome of interest.
Exercise has been shown to be an effective nondrug
intervention for pain in older adults; thus, it is reasonable to
assume that it may be beneficial for pain in those with
dementia.57 Choice of an exercise intervention, however,
should take into consideration the individual’s physical and
cognitive status, health conditions, risk of falls, level of fitness,
prior and current physical activity, support for implementation,
and environmental factors. Approaches need to be tailored to
the individuals understanding and abilities, capitalizing on
significant other support/assistance with reasonable and
achievable goals (Table 2).
Psychological interventions have a strong evidence base in
adult samples, and growing evidence in older adults;10 however,
research is sparse on use in dementia. Impairments in memory,
language, executive function, visuospatial skill, and other pro-
cesses impact the ability to effectively engage in these pain
interventions, such as cognitive-behavioral therapy, mindfulness
approaches (including biofeedback and relaxation training), and
self-regulatory approaches (including biofeedback, relaxation
training, and hypnotherapy). It is likely that these interventions are
not feasible in those with moderate and severe dementia.
Recent reviews of nonpharmacologic interventions for the
treatment of BPSD, including agitation and disruptive behavior
that have both been associated with pain, provide some
guidance. In a review of systematic reviews evaluating RCTs,
Dyer et al.23 note that although quality of evidence for non-
pharmacological interventions is low, lack of adverse events
supports trialing techniques with potential benefit. Functional
analysis-based interventions, such as behavior management and
music therapy, demonstrated statistically significant improve-
ments in BPSD. A second review of reviews conducted by Legere
et al.44 on nonpharmacological approaches for BPSD not limited
to RCTs concluded that there continues to be sparse high-quality
evidence, with the strongest support for music therapy.
Pieper et al.51 found that behavioral interventions targeting
pain, including music therapy, cognitive behavioral therapy,
reflexology, Reiki, person-centered bathing or showering, and
rocking chair therapy, were effective in reducing pain and
behavioral symptoms in dementia. A recent integrative review
examined the state of science on nonpharmacological interven-
tion use for pain for older adults in long-term care facilities, many
of which have dementia.62 Exercise, massage, heat therapy, and
relaxation/rest were identified as significant interventions for
persistent noncancer pain. Finally, a recent review of RCTs
focused on complementary and alternative interventions to treat
pain and agitation in dementia found massage, touch, and
human interaction and presence are effective in reducing pain
and agitation.6 Although evidence for efficacy is limited in this
setting, incorporation of strategies that caregivers identify as
potentially useful for the older person with dementia can be
encouraged.
It is difficult to knowwhether any of the nonpharmacologic pain
interventions are superior to another or when and how their use
should be tailored to the individual’s unique needs and
characteristics. Studies are needed that use strong designs,
include valid and reliable pain behavior outcomes, examine
impact of dose of intervention, and establish feasibility, applica-
bility, and cost-effectiveness for use in the long-term care setting.
4. New developments in
pharmacological management
When it is not possible to relieve pain by either targeting the cause
of pain and/or applying nonpharmacological strategies alone,
pharmacological treatment of pain is necessary and remains
a cornerstone in the care for people with dementia. The overall
use of analgesics in nursing home patients is increasing
worldwide.42 Dementia is common among nursing home
patients, and despite concern that pain may be underdiagnosed
in people with dementia, several studies have found that in more
recent cohorts, nursing home patients with dementia were no
less likely to receive analgesics compared to those without.35,56
However, these findings were predominantly from Scandinavian
countries.
Table 2
Most promising nonpharmacologic interventions for use in
dementia.
Music therapy
Exercise and/or movement therapies (eg, rocking chair)
Massage and/or human touch
Heat and relaxation therapies
Human interaction and presence
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4.1. Paracetamol
Paracetamol/acetaminophen remains the mainstay for treat-
ing mild-to-moderate pain in advanced dementia, as reflected
by 2 of the publications with most recent data reporting that
48% (2011; Norway) and 71% (2014; Australia) of nursing
home patients with dementia receive paracetamol.26,56,64,
However, these figures are not directly comparable because
analgesic use was defined as regular prescriptions only in the
2011 cohort, whereas the 2014 cohort included any use during
the last 24 hours. Although limited, the available evidence
suggests that paracetamol is effective and safe, and therefore
represents an appropriate first choice for analgesic treatment
in this population.26,34,64 It should be noted that although long-
term use of paracetamol is common in people with dementia,
no study has investigated the efficacy and safety of long-term
treatment exceeding 3 months.26,34,64
4.2. Nonsteroidal anti-inflammatory drugs
Long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs)
is associated with increased risk of potentially serious adverse
events, and should be avoided.4,26 Use of NSAIDs in people with
dementia has decreased in recent years, and is generally low—in
a sample of 169 nursing home patients with dementia in Australia
in 2014, only 2.4% had received an NSAID during the last 24
hours.56,64 No study has investigated the risk and benefit of short-
term use of NSAIDs for treating moderate-to-severe pain in
people with dementia.26 The appropriate choice of NSAID, dose,
and duration of use remains unclear and should be investigated
further—it is possible that new evidence may place NSAIDs as an
appropriate alternative to other agents with higher potential for
cognitive and behavioral adverse effects, such as opioids, for
treating acute pain of short duration in people with dementia.26
4.3. Opioids
Opioid analgesics are commonly prescribed for noncancer acute
or chronic pain in people with dementia, and their use in this
population has rapidly increased over the past decades.35,55
However, current developments highlight the need to investigate
efficacy and safety in this population.26 Buprenorphine is
a relatively new opioid analgesic with mixed activity and high
potency. It has become increasingly prescribed to people with
dementia because it is marketed as an easily administered
transdermal patch formulation at low equianalgesic dose
levels.35,56 The first double-blinded trial of buprenorphine in
people with advanced dementia found high risk of adverse events
and the adverse symptoms that were described overlapped with
common BPSD in dementia such as changes in personality,
confusion, sedation, or somnolence.25 This suggests that people
with dementia may experience unexpected adverse symptoms
that may go unnoticed in this population. Oxycodone and
morphine are the only other opioids that have been tested in
randomized controlled trials including people with dementia, and
all trials were limited by a low number of participants.26,34
Although the results must be interpreted with caution due to lack
of comparability between trials, the available evidence suggests
that all treatments seem to reduce pain, and that oxycodone and
morphine may be better tolerated.34,55 However, the relative
efficacy and tolerability of different opioids in people with
dementia and pain must be investigated further to establish
evidence-based treatment guidelines and minimize the risk of
harm while promoting pain relief.
4.4. Adjuvant analgesics
No clinical trials have investigated the safety and efficacy of
adjuvant analgesics such as antidepressants and antiepileptic
drugs for treating pain in dementia.34,55 People with dementia
may be at increased risk of adverse events of psychotropic drugs,
as well as drug–drug and drug–disease interactions. The
risk–benefit relationship may therefore be skewed in this
population, and studies of adjuvant analgesics for treating pain
are needed to make evidence-based treatment decisions in this
population.
4.5. Unresolved issues
Several important unresolved issues remain in relation to current
guidelines and practice for the use of analgesic drugs in people
with dementia. No evidence-based guidelines exist for treating
pain in people with dementia; instead, general guidelines for the
geriatric population are applied to this group despite lack of
evidence for efficacy and safety in people with dementia. Clinical
practice for pain management in people with advanced dementia
also varies widely both within and across nations. Although
several studies show that the overall use of analgesics is
increasing, we do not know whether the right patients receive
appropriate analgesic treatment in the correct dose. Recent
studies show that not all those who receive analgesics have pain;
similarly, many still have pain despite receiving analgesic
treatment.24 The most recent data from 2014 report that within
a Norwegian cohort of 407 nursing home residents with
advanced dementia, 54.1% used paracetamol and 32.7% used
opioids on a daily basis.69 On average, those who received
analgesics had more pain compared to those who did
not—however, in the former group, 46% were still registered as
having mild or no pain.69 Most studies on medication use in
dementia are cross-sectional and cannot determine whether the
administered treatment is appropriate and had the intended
effect—for those who still have pain, we do not know whether
treatment has reduced pain intensity or not. Similarly, for those
with no registered pain, we do not know whether they have been
successfully treated, or whether treatment is even indicated.
Therefore, a trend towards increased prescribing of analgesics in
people with dementia does not equate improved quality of care.3
Longitudinal data, with assessments before and after treatment,
and randomized pain intervention studies in particular are needed
to evaluate the current quality of care and shed light on potential
areas of improvement.
4.6. Interdisciplinary pain management and implementation
in long term care
As with any patient with persistent pain, development of
a comprehensive treatment plan is essential and, in the
population of dementia, in particular, an interdisciplinary ap-
proach is key to establishment of a multimodal pain management
plan. An interdisciplinary approach includes comprehensive
assessment, managing polypharmacy and pharmacotherapy,
psychological evaluation and support, physical rehabilitation, and
interventions and interventional procedures.38 Before institution-
alization, the team includes the person with dementia and their
family caregiver to assure a patient-centered approach that
incorporates the values, preferences, and needs of the person
with dementia.76 When institutionalized, expertise in geriatric
syndromes and conditions, knowledge of the complexities of
pharmacotherapy and comorbidities, skill in recognizing,
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assessing and monitoring pain in those unable to self-report, and
understanding of the long-term care environment and its impact
on the older person with dementia are needed.
Organizations invested in an interdisciplinary team approach to
managing the problems associated with dementia are best
prepared to gather information that informs the treatment plan
and engages individuals most likely to be effective in implement-
ing thepainmanagement plan.Challenges of creating a functional
interdisciplinary team need to be addressed by the organization
to promote use of nondrug therapies and establish reimburse-
ment for multiple providers and nondrug therapies for pain
management.77 Organizational policies and procedures are
necessary that establish the approach to pain assessment in
dementia and evidence-based pain management strategies, as
well as resources for staff education and implementation of
nonpharmacological interventions.
5. Conclusion
Pain is a challenge for persons with dementia, their loved ones,
health care professionals, and society. Although in the past
decade better assessment procedures including observational
pain instruments have been developed and studied, implemen-
tation in practice is still disappointing. Good pain management is
unfortunately also not implemented, which this is partly due to
a lack of good studies on both pharmacological and non-
pharmacological management. To effectively assess and man-
age pain in this vulnerable group, interdisciplinary collaboration
(nurses, physicians, psychologists, computer scientists, and
engineers) is essential. This article provides the latest state of the
literature on this topic.
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